International Cooperation in Pharmaceutical Research
This paper aims at examining whether an increased stringency of Intellectual Property Right (IPR) protection is apt to stimulate international cooperation on research projects between developed and emerging countries. To address this issue, we look both at scientific and technological collaborations within the pharmaceutical domain, and we adopt a gravity framework to assess the impact of the IPR level on bilateral R&D cooperation. The analysis is conducted using data from patent and publication databases, and the results provide a sound test of conflicting theories on IPR enforcement and international collaborations in pharmaceutical research.
|Date of creation:||Oct 2009|
|Date of revision:|
|Contact details of provider:|| Postal: |
Web page: http://www.dse.univr.it
More information through EDIRC
When requesting a correction, please mention this item's handle: RePEc:ver:wpaper:62/2009. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Michael Reiter)
If references are entirely missing, you can add them using this form.